Concepedia

Gemma L. Kelly

GL

44

Publications

4.3K

Citations

31

H-Index

2001

Active since

Affiliations

Walter and Eliza Hall Institute of Medical Research(Current)

The University of Melbourne

University of Birmingham

Cancer Research UK

The Royal Melbourne Hospital

Gemma L. Kelly is an author at Walter and Eliza Hall Institute of Medical Research specializing in medicine, tumor biology, and cell biology.

Top concepts

MedicineCell BiologyTumor BiologyImmunologyCell DeathCancer ResearchPathologyRadiation OncologyApoptosisTumor Microenvironment

Publications per year

2001–2024

44

Publications

44

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models

András Kotschy, Zoltán Szlávik, James B. Murray et al. · Nature · 2016 · 1K citations

Mcl1 Inhibitor S63845, Systems Biology, Oncology +11

An Inducible Lentiviral Guide RNA Platform Enables the Identification of Tumor-Essential Genes and Tumor-Promoting Mutations In Vivo

Brandon J. Aubrey, Gemma L. Kelly, Andrew J. Kueh et al. · Cell Reports · 2015 · 414 citations · Full text

Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth

Jonathan B. Baell, David J. Leaver, S.J. Hermans et al. · Nature · 2018 · 300 citations · Full text

Cancer Research, Chromatin, Tumour Growth +12

Epstein–Barr virus–associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2

Gemma L. Kelly, Andrew Bell, Alan B. Rickinson · Nature Medicine · 2002 · 219 citations

Lymphoid Neoplasia, Lymphocyte Development, Immune Cell Development +10

VDAC2 enables BAX to mediate apoptosis and limit tumor development

Hui San Chin, Xiang Li, Iris K. L. Tan et al. · Nature Communications · 2018 · 182 citations · Full text

Rows per page

1–5 of 44